ZNF697 is an RNA-interacting protein that functions as a damage-induced regulator of muscle remodeling and inflammation. Primary function: ZNF697 acts as an RNA-binding protein with extensive miRNA targeting capacity 1. It mediates the interferon-gamma response in muscle cells, serving as an essential integrator of cell-cell communication during tissue remodeling 1. Mechanism: ZNF697 expression is transiently elevated during recovery from muscle atrophy or injury in both mice and humans 1. Myofiber-specific expression drives chemokine secretion, immune cell recruitment, and extracellular matrix remodeling, with myofiber ablation sufficient to impair inflammatory and regenerative responses 1. Disease relevance: Beyond skeletal muscle, ZNF697 variants associate with interferon-beta treatment response in multiple sclerosis, with polymorphisms potentially predicting therapeutic outcomes 23. ZNF697 expression correlates with glycine receptor activity in pancreatic β cells, contributing to gene regulatory networks involved in glucose homeostasis 4. Clinical significance: A four-gene prognostic score incorporating ZNF697 expression strongly predicts recurrence risk in stage II colon cancer (HR=5.00, p<0.001), surpassing conventional clinical risk factors 5. These findings identify ZNF697 as a multifunctional regulator relevant to muscle regeneration, autoimmunity, metabolic dysfunction, and cancer prognosis.